Cipla slides as Goa facility gets 6 USFDA observations 0 24.06.2024 07:17 Business Standard Cipla declined 1.71% to Rs 1,514.55 after the drug major said that the US drug regulator has issued Form 483, with six observations after inspecting its Goa manufacturing facility. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
